Clinical trial

Nano-crystalline Megestrol Acetate for Anorexia-Cachexia Syndrome in Advanced Lung Cancer

NCT07092137

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-10-10

PhasePHASE2

Study timeline

Study start (estimated)2025-10-10Date precision: day

Registry last updated2025-07-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Cachexia-Anorexia Syndromeunresolved

Interventions

Nano-crystalline Megestrol Acetate Oral SuspensionDRUG

Nano-crystalline Megestrol Acetate Oral Suspension placeboOTHER

Sponsors & collaborators

Guangzhou Institute of Respiratory Diseaselead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07092137 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.